We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$396B
AUM Growth
-$4.47B
Cap. Flow
+$17.3B
Cap. Flow %
4.36%
Top 10 Hldgs %
17.57%
Holding
6,885
New
459
Increased
2,707
Reduced
2,368
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 15.47%
2 Healthcare 9.44%
3 Financials 9.02%
4 Consumer Discretionary 7.88%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNST.WS
5826
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$17K ﹤0.01%
249,850
BHACW
5827
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$17K ﹤0.01%
114,400
QFTA.WS
5828
DELISTED
Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50
QFTA.WS
$17K ﹤0.01%
457,573
CTSO icon
5829
Cytosorbents Corp
CTSO
$23.7M
$16K ﹤0.01%
11,618
-44,096
-79% -$86.1K
NRXP icon
5830
NRX Pharmaceuticals
NRXP
$131M
$16K ﹤0.01%
2,162
-89
-4% -$600
FTH
5831
Faeth Therapeutics
FTH
$634M
$16K ﹤0.01%
522
-31
-6% -$1.22K
YSG
5832
Yatsen Holding
YSG
$300M
$16K ﹤0.01%
2,920
-118,920
-98% -$780K
ABPWW
5833
DELISTED
Abpro Holdings Warrant
ABPWW
$16K ﹤0.01%
266,600
+87,500
+49% +$7.36K
NAGE
5834
Niagen Bioscience
NAGE
$234M
$16K ﹤0.01%
13,364
-309,714
-96% -$498K
ACAHW
5835
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
$16K ﹤0.01%
392,003
CCVI.WS
5836
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$16K ﹤0.01%
113,490
-14,472
-11% -$3.06K
NMTR
5837
DELISTED
9 Meters Biopharma
NMTR
$16K ﹤0.01%
3,817
-234
-6% -$1.16K
WLMS
5838
DELISTED
Williams Industrial Services Group Inc.
WLMS
$16K ﹤0.01%
10,962
-2,558
-19% -$3.82K
CRECW
5839
DELISTED
Crescera Capital Acquisition Corp Warrant
CRECW
$16K ﹤0.01%
264,379
-500
-0.2% -$56
VLDRW
5840
DELISTED
Velodyne Lidar, Inc. Warrants
VLDRW
$16K ﹤0.01%
40,067
ALGS icon
5841
Aligos Therapeutics
ALGS
$29.3M
$15K ﹤0.01%
562
-3,396
-86% -$113K
CIFR icon
5842
Cipher Digital
CIFR
$7.77B
$15K ﹤0.01%
+12,012
New +$21.1K
CRBP icon
5843
Corbus Pharmaceuticals
CRBP
$177M
$15K ﹤0.01%
2,953
-238
-7% -$1.68K
FEMY icon
5844
Femasys
FEMY
$9.09M
$15K ﹤0.01%
+662
New +$24.9K
ICUCW
5845
SeaStar Medical Holding Corp Warrant
ICUCW
$336K
$15K ﹤0.01%
211,381
RTB
5846
RTB Digital
RTB
$230M
$15K ﹤0.01%
44
+8
+22% +$2.88K
TISI icon
5847
Team
TISI
$78M
$15K ﹤0.01%
1,394
-7,653
-85% -$82K
GPUS
5848
Hyperscale Data Inc
GPUS
$55.6M
$15K ﹤0.01%
+1
New +$46.2K
ASXC
5849
DELISTED
Asensus Surgical, Inc.
ASXC
$15K ﹤0.01%
34,222
-89,240
-72% -$46.5K
CNGLW
5850
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
$15K ﹤0.01%
585,385

Similar funds

Goldman Sachs's Q3 2022 Portfolio in Review

As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.

  • Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
  • Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
  • Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
  • Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
  • Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
  • Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
  • Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.